EUVIMEDEUVIMED entdecken
Crossref

Retraction of: Dapagliflozin preserves kidney function and reduces albuminuria in children with chronic kidney disease

Nephrology Dialysis Transplantation · 10.11.2026

DOI: 10.1093/ndt/gfag234 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 10.11.2026. Die Arbeit nennt 1 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Retraction of: Dapagliflozin preserves kidney function and reduces albuminuria in children with chronic kidney disease. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfag234

Vancouver

Retraction of: Dapagliflozin preserves kidney function and reduces albuminuria in children with chronic kidney disease. Nephrology Dialysis Transplantation. 2026. doi:10.1093/ndt/gfag234

BibTeX
@article{euvimed2026,
  title = {Retraction of: Dapagliflozin preserves kidney function and reduces albuminuria in children with chronic kidney disease},
  journal = {Nephrology Dialysis Transplantation},
  year = {2026},
  doi = {10.1093/ndt/gfag234}
}
Kostenlos starten →